Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 3
2017 22
2018 30
2019 29
2020 13
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

86 results
Results by year
Filters applied: . Clear all
Page 1
Treatment of Heart Failure with Preserved Ejection Fraction.
Ilieșiu AM, Hodorogea AS. Ilieșiu AM, et al. Adv Exp Med Biol. 2018;1067:67-87. doi: 10.1007/5584_2018_149. Adv Exp Med Biol. 2018. PMID: 29498023 Review.
HFpEF has a significant morbidity and mortality and so far no treatment has been clearly demonstrated to improve the outcomes in HFpEF, in contrast to the efficacy of treatment in heart failure with reduced ejection fraction (HFrEF).The failure of proven beneficial …
HFpEF has a significant morbidity and mortality and so far no treatment has been clearly demonstrated to improve the outcomes in HFpE …
Sex Differences in Heart Failure.
Savarese G, D'Amario D. Savarese G, et al. Adv Exp Med Biol. 2018;1065:529-544. doi: 10.1007/978-3-319-77932-4_32. Adv Exp Med Biol. 2018. PMID: 30051405 Review.
The overall HF prevalence and incidence are ~2% and ~0.2% per year, respectively, in Western countries, with half of the HF population with reduced ejection fraction (HFpEF) and half with preserved (HFpEF) or mid-range ejection fraction (HFmrEF). Sex differences may exist …
The overall HF prevalence and incidence are ~2% and ~0.2% per year, respectively, in Western countries, with half of the HF population with …
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions.
Hsu JJ, Ziaeian B, Fonarow GC. Hsu JJ, et al. JACC Heart Fail. 2017 Nov;5(11):763-771. doi: 10.1016/j.jchf.2017.06.013. Epub 2017 Oct 11. JACC Heart Fail. 2017. PMID: 29032140 Free PMC article. Review.
This review summarizes what is known about the clinical epidemiology, pathophysiology, and prognosis for patients with HFmrEF and how these features compare with the more well-studied HF groups. Although recommended treatments currently focus on aggressive ma …
This review summarizes what is known about the clinical epidemiology, pathophysiology, and prognosis for patients with HFmrEF
Heart Failure With Mid-range Ejection Fraction.
Srivastava PK, Hsu JJ, Ziaeian B, Fonarow GC. Srivastava PK, et al. Curr Heart Fail Rep. 2020 Feb;17(1):1-8. doi: 10.1007/s11897-019-00451-0. Curr Heart Fail Rep. 2020. PMID: 31925667 Free PMC article. Review.
PURPOSE OF REVIEW: To describe the epidemiology, pathophysiology, management, and prognosis of patients with heart failure with mid-range ejection fraction (HFmrEF). ...HFmrEF is a complex disorder that remains poorly understood. Future research is needed to …
PURPOSE OF REVIEW: To describe the epidemiology, pathophysiology, management, and prognosis of patients with heart failure with mid-r …
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP, Parissis J, Laroche C, Piepoli MF, Fonseca C, Mebazaa A, Lund L, Ambrosio GA, Coats AJ, Ferrari R, Ruschitzka F, Maggioni AP, Filippatos G. Chioncel O, et al. Eur J Heart Fail. 2017 Dec;19(12):1574-1585. doi: 10.1002/ejhf.813. Epub 2017 Apr 6. Eur J Heart Fail. 2017. PMID: 28386917 Free article.
The HFmrEF group resembled the HFrEF group in some features, including age, gender and ischaemic aetiology, but had less left ventricular and atrial dilation. ...Low systolic blood pressure and high heart rate were predictors for mortality in HFrEF and HFmrEF. A low …
The HFmrEF group resembled the HFrEF group in some features, including age, gender and ischaemic aetiology, but had less left ventric …
Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction.
Tromp J, Khan MAF, Mentz RJ, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JGF, Givertz MM, Bloomfield DM, Van Veldhuisen DJ, Hillege HL, Voors AA, van der Meer P. Tromp J, et al. JACC Heart Fail. 2017 Jul;5(7):507-517. doi: 10.1016/j.jchf.2017.04.007. Epub 2017 Jun 14. JACC Heart Fail. 2017. PMID: 28624483 Free article. Clinical Trial.
HFpEF was defined as left ventricular ejection fraction (LVEF) of 50% (n = 108), HFrEF as LVEF of <40% (n = 607), and HFmrEF as LVEF of 40% to 49% (n = 128). RESULTS: Hemoglobin and brain natriuretic peptide levels (300 pg/ml [HFpEF]; 397 pg/ml [HFmrEF]; 521 pg/m …
HFpEF was defined as left ventricular ejection fraction (LVEF) of 50% (n = 108), HFrEF as LVEF of <40% (n = 607), and HFmrEF as LV …
Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
Savarese G, Vedin O, D'Amario D, Uijl A, Dahlström U, Rosano G, Lam CSP, Lund LH. Savarese G, et al. JACC Heart Fail. 2019 Apr;7(4):306-317. doi: 10.1016/j.jchf.2018.11.019. Epub 2019 Mar 6. JACC Heart Fail. 2019. PMID: 30852236 Free article.
RESULTS: Of 4,942 patients at baseline, 18% had HFpEF, 19% had HFmrEF, and 63% had HFrEF. During follow-up, 21% and 18% of HFpEF patients transitioned to HFmrEF and HFrEF, respectively; 37% and 25% of HFmrEF patients transitioned to HFrEF and HFpEF, respectiv …
RESULTS: Of 4,942 patients at baseline, 18% had HFpEF, 19% had HFmrEF, and 63% had HFrEF. During follow-up, 21% and 18% of HFpEF pati …
A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
Koh AS, Tay WT, Teng THK, Vedin O, Benson L, Dahlstrom U, Savarese G, Lam CSP, Lund LH. Koh AS, et al. Eur J Heart Fail. 2017 Dec;19(12):1624-1634. doi: 10.1002/ejhf.945. Epub 2017 Sep 25. Eur J Heart Fail. 2017. PMID: 28948683 Free article.
CONCLUSIONS: HFmrEF was an intermediate phenotype, except that CAD was more common in HFmrEF and HFrEF vs. HFpEF, crude all-cause mortality was lower in HFmrEF and HFrEF, adjusted all-cause mortality was lower in HFmrEF and HFpEF, and CAD portended a h …
CONCLUSIONS: HFmrEF was an intermediate phenotype, except that CAD was more common in HFmrEF and HFrEF vs. HFpEF, crude all-ca …
Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.
Abdul-Rahim AH, Shen L, Rush CJ, Jhund PS, Lees KR, McMurray JJV; VICCTA-Heart Failure Collaborators. Abdul-Rahim AH, et al. Eur J Heart Fail. 2018 Jul;20(7):1139-1145. doi: 10.1002/ejhf.1160. Epub 2018 Mar 1. Eur J Heart Fail. 2018. PMID: 29493058 Free article. Clinical Trial.
Event rates in patients with HFmrEF were similar to those in HFpEF and much lower than in HFrEF. ...The digoxin/placebo HR for the composite of HF death or HF hospitalisation was 0.74 (95% CI 0.68-0.81) in HFrEF, 0.83 (95% CI 0.66-1.05) in HFmrEF and 0.88 (95% CI 0. …
Event rates in patients with HFmrEF were similar to those in HFpEF and much lower than in HFrEF. ...The digoxin/placebo HR for the co …
Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
Sartipy U, Dahlström U, Fu M, Lund LH. Sartipy U, et al. JACC Heart Fail. 2017 Aug;5(8):565-574. doi: 10.1016/j.jchf.2017.05.001. Epub 2017 Jul 12. JACC Heart Fail. 2017. PMID: 28711451 Free article.
The importance of AF in HFpEF and HFmrEF is less well known. METHODS: In patients from 2000 to 2012 in the SwedeHF (Swedish Heart Failure Registry) registry, enriched with patient-level data from national health care registries, the authors assessed prevalence of, associat …
The importance of AF in HFpEF and HFmrEF is less well known. METHODS: In patients from 2000 to 2012 in the SwedeHF (Swedish Heart Fai …
86 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page